Lataa...
Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series
BACKGROUND. Gonorrhea is the second most commonly reported notifiable condition in the United States. Infrequently, Neisseria gonorrhoeae can cause disseminated gonococcal infection (DGI). Eculizumab, a monoclonal antibody, inhibits terminal complement activation, which impairs the ability of the im...
Tallennettuna:
| Julkaisussa: | Clin Infect Dis |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6744347/ https://ncbi.nlm.nih.gov/pubmed/30418536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy958 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|